NCT04205929View on ClinicalTrials.gov

Use of Curcumin to Treat Unfavorable Bleeding Patterns in Contraceptive Implant Users

PHASE4CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

April 15, 2020

Primary Completion Date

November 5, 2022

Study Completion Date

August 1, 2023

Conditions
BleedingImplantsBreakthrough Bleeding
Interventions
DRUG

Placebo

Placebo (oral) once daily for 30 days. Treatment to be started after 3 consecutive days of bleeding

DRUG

Curcumin

Curcumin 600 mg (oral) once daily for 30 days. Treatment to be started after 3 consecutive days of bleeding

Trial Locations (1)

97239

OHSU, Portland

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Oregon Health and Science University

OTHER

NCT04205929 - Use of Curcumin to Treat Unfavorable Bleeding Patterns in Contraceptive Implant Users | Biotech Hunter | Biotech Hunter